In response to the uncertainty surrounding hydroxychloroquine's use, regulatory agencies have issued guidelines recommending against its routine use for COVID-19 outside of clinical trials or emergency use authorizations.
hydroxychloroquine These recommendations are based on the latest available evidence and aim to protect patient safety while promoting responsible research.
